The Microbiota I-Centre of CUHK has identified distinct gut microbiome profiles that can characterise “long COVID”. This is the world’s first study to demonstrate gut microbiota as a key determinant of long COVID. These distinct gut microbial signatures can be used as a diagnostic tool and to guide therapy.

Playing a major role in enhancing the quality of human life, healthcare technologies, artificial intelligence and robotics technologies are the international global trends in the development of innovation and technology. CUHK has established six InnoHK Centres covering health, biomedicine, robotics and artificial intelligence in partnership with prestigious global universities.